Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24637996

Emerging role for bevacizumab in combination with chemotherapy for patients with platinum-resistant ovarian cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2014 May 1
First author
Liu JF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 May 1;32(13):1302-8. doi: 10.1200/JCO.2013.51.4489.
    note
    Source null
    related pmid
    24637997
    relationship
    Comment on
  2. citation
    J Clin Oncol. 2014 May 1;32(13):1309-16. doi: 10.1200/JCO.2013.51.4240.
    note
    Source null
    related pmid
    24687829
    relationship
    Comment on

Authors and identifiers

  1. name
    Liu JF
    type
    Author
  2. name
    Cannistra SA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Liu JF
    type
    Author
  2. name
    Cannistra SA
    type
    Author
bibliography ids
  1. nci-bib-3c77f163ccac8802e9546728
book metadata
content sha256
2fe23992f77d191eab5dfb0f3a56da5026d43ba31dc59a2b71d0753f1f37e5c9
document type
citation
dois
  1. 10.1200/JCO.2013.54.7299
electronic publication date
display
2014 Mar 17
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:24637996
immutable id
pubmed:24637996@2fe23992f77d191eab5dfb0f3a56da5026d43ba31dc59a2b71d0753f1f37e5c9
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
13
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1287-9
volume
32
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 May 1;32(13):1302-8. doi: 10.1200/JCO.2013.51.4489.
    note
    Source null
    related pmid
    24637997
    relationship
    Comment on
  2. citation
    J Clin Oncol. 2014 May 1;32(13):1309-16. doi: 10.1200/JCO.2013.51.4240.
    note
    Source null
    related pmid
    24687829
    relationship
    Comment on
outcomes validated
false
pmid
24637996
provenance
batch id
063b6c38419f18d4021f
provider
NCBI PubMed ESummary
record sha256
d2c385437835761dd0946c414edf7b94e3d9dd8654665608bf3234b64e6556b2
response sha256
5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
retrieved at
2026-09-09T23:47:02.607425+00:00
publication date
display
2014 May 1
precision
day
year
2014
publication types
  1. Editorial
  2. Comment
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24637996/
title
Emerging role for bevacizumab in combination with chemotherapy for patients with platinum-resistant ovarian cancer.

Preserved source evidence · Not medical advice